Myopia Progression Pipeline Drugs and Key Companies Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape and Market Size By DelveInsight

DelveInsight’s Myopia Progression Report delivers an in-depth understanding of the Myopia Progression, historical and forecasted epidemiology as well as the Myopia Progression market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some Key Highlights from the Myopia Progression Market Report

• According to Morgan et al. (2017), the prevalence of myopia in young adults is about 80–90%, with a strong prevalence of high myopia in the same age group (10-20 percent).
• According to a report by Nemeth J. et al titled “Update and Guidance on Management of Myopia” (2021), average annual progression rates for myopia and axial length in White European children were 0.41 D and 0.30 mm between 6 and 16 years of age, and 0.16 D and 0.15 mm between 12 and 22 years of age.
• Key Pipeline therapies in the Myopia Progression market include NVK-002 (Nevakar), Micropine (Eyenovia Bio), SYD-101 (Sydnexis), DE-127 (Santen Pharmaceutical) and others.
• Key Companies involved in the Myopia Progression are Nevakar, Eyenovia Bio, Sydnexis, Santen Pharmaceutical, among others.
• During the study period, 2018–2030, the demand for Myopia Progression is expected to grow.

Request Sample Page @ Myopia Progression Market Insights

The Myopia Progression market report covers existing clinical practises, new drugs, individual therapies’ market share, and current and forecasted Myopia Progression market sizes in the 7MM (the United States, the EU5, Germany, Italy, Spain, and France), as well as Japan.

Myopia Progression: Disease Overview

Myopia is a group of ocular conditions in which the eye’s far point is closer to the retina than infinity. It is rapidly spreading across the world and posing a significant public health threat. As a result, refractive error is identified as one of the top five causes of blindness and visual impairment in the world by the global initiative to eliminate avoidable blindness.

One of the most important risk factors for myopia is age, and visual stress caused by detailed work, such as reading or using a device, contributes to the development and progression of myopia over time.

Myopia Progression Epidemiology Segmentation

• Myopia Prevalence
• Myopia Specific-Severity Prevalence
• Myopia Progression Prevalence
• Myopia Progression Diagnosed and Treated Cases

To know more about epidemiology visit, Myopia Progression Epidemiology

Myopia Progression Treatment Landscape

There are no licensed treatments for myopia, so the only way to stop it from getting worse is to use optical correction such as:

• Bifocal Spectacle Lenses
• Progressive Addition Spectacle Lenses
• Under-Correction
• Orthokeratology
• Multifocal Contact Lenses
• Increased Exposure to Outdoor Activities
• Use of Atropine eye drops

Myopia Progression Market

New therapies are expected to join the Myopia Progression market from companies such as Nevakar, Eyenovia Bio, Sydnexis, and Santen Pharmaceutical, among others.

In the forecast period 2018-30 in the 7MM, the launch of NVK-002 (Nevakar), Micropine (Eyenovia Bio), SYD-101 (Sydnexis), and DE-127 (Santen Pharmaceutical) are expected to give the Myopia Progression market a major boost.

Furthermore, the Myopia Progression market is being propelled forward by extensive R&D in the domain, as well as rising Myopia Progression prevalence.

Myopia Progression Pipeline Therapies and Key Companies

• NVK-002: Nevakar
• Micropine: Eyenovia Bio
• SYD-101: Sydnexis
• DE-127: Santen Pharmaceutical

To get more details about emerging drugs and companies visit, Myopia Progression Pipeline Drugs and Major Players

Table of Contents

Know more about report offering @ Myopia Progression Market

Related Reports

Myopia Market

DelveInsight’s “Myopia – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Myopia, historical and forecasted epidemiology as well as the Myopia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Adult Myopia Market

Get comprehensive historical and forecast analysis of Adult Myopia Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Bayer AG, Genentech, among others.

Centronuclear Myopathy Market

DelveInsight’s ‘Centronuclear Myopathy Market Insights, Epidemiology, and Market Forecast-2030’ report delivers an in-depth understanding of the Centronuclear Myopathy, historical and forecasted epidemiology as well as the Centronuclear Myopathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Inclusion Body Myositis Market

DelveInsight’s “Inclusion Body Myositis – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Inclusion Body Myositis, historical and forecasted epidemiology as well as the Inclusion Body Myositis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Mitochondrial Myopathies Market

DelveInsight’s “Mitochondrial Myopathies – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Mitochondrial Myopathies , historical and forecasted epidemiology as well as the Mitochondrial Myopathies market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Myocardial Infarction Market

DelveInsight’s “Myocardial Infarction – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Myocardial Infarction, historical and forecasted epidemiology as well as the Myocardial Infarction market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Myocarditis Market

Get comprehensive historical and forecast analysis of Myocarditis Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Cardiol Therapeutics, among others.

Myotonic Dystrophy Market

DelveInsight’s “Myotonic Dystrophy – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Myotonic dystrophy, historical and forecasted epidemiology as well as the Myotonic dystrophy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Sporadic Inclusion Body Myositis Market

DelveInsight’s “Sporadic Inclusion Body Myositis (sIBM) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Sporadic Inclusion Body Myositis (sIBM), historical and forecasted epidemiology as well as the Sporadic Inclusion Body Myositis (sIBM) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Multiple Myeloma Market

Get comprehensive historical and forecast analysis of Multiple Myeloma Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Johnson & Johnson, Amgen,  BioLineRx, Bristol-Myers Squibb, ExCellThera, Pfizer,  Takeda, Precision BioSciences,  Poseida Therapeutics, among others.

Get in touch with our Business executive for Competitive Insights and Due Diligence Services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance. 

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Information:

Sandeep Joshi 

info@delveinsight.com 

+1(919)321-6187 

www.delveinsight.com

Connect With Us at:

LinkedIn | Facebook | Twitter